Fludarabine, Ara-C, Cyclophosphamide, Cisplantinum and GM_CSF (FACPGM) treatment of patients with refractory chronic lymphocytic leukemia (CLL), CLL in transformation, and other refractory lymphoproliferative disorders
Contributors: International Oncology Study Group
Publisher: International Oncology Study Group
Place of publication: Pacific Palisades, CA
Language: eng
Subjects: Chronic lymphocytic leukemia
Notes: 27